HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.95

Change

-0.04 (-0.44)%

Market Cap

N/A

Volume

6.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.06 (-0.22%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.46B
XEQT:CA iShares Core Equity Portfolio

-0.01 (-0.03%)

CAD 5.15B
PHYS-U:CA Sprott Physical Gold Trust

+0.16 (+0.75%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.07 (+0.19%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.28 (-0.61%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.40 (+1.54%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.26 (+2.28%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.59B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.42% 32% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.42% 33% F 37% F
Trailing 12 Months  
Capital Gain 16.69% 39% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.69% 39% F 42% F
Trailing 5 Years  
Capital Gain 15.63% 40% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.63% 40% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 3.33% 58% F 48% F
Dividend Return 3.74% 60% D- 44% F
Total Return 0.41% 88% B+ 27% F
Risk Return Profile  
Volatility (Standard Deviation) 7.24% 59% D- 81% B-
Risk Adjusted Return 51.57% 73% C 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike